Bioretec
-
Financial
Bioretec Ltd’s Annual Report and Financial Statements 2023 published
Bioretec Ltd Company announcement 15 March 2024 at 5:30 p.m. EET TAMPERE, Finland, March 15, 2024 /PRNewswire/ — Bioretec Ltd has today published its 2023…
Read More » -
Spine
Inside information: Bioretec has been granted FDA Breakthrough Device Designation status for its RemeOs™ Spinal Interbody Cage
TAMPERE, Finland, March 14, 2024 /PRNewswire/ — Bioretec Ltd., a pioneer in biodegradable orthopedic implants, has today been granted Breakthrough Device Designation…
Read More » -
Financial
Bioretec Ltd’s financial statements bulletin 2023: Another successful year in the growth trajectory
Bioretec Ltd Company announcement 16 February 2024 – TAMPERE, Finland, Feb. 16, 2024 /PRNewswire/ — This announcement is a summary of Bioretec Ltd’s financial statements…
Read More » -
Financial
CORRECTION: Bioretec Ltd’s Board of Directors has decided on a new option program 2023-1
TAMPERE, Finland, Oct. 20, 2023 /PRNewswire/ — “CORRECTION: Bioretec Ltd corrects the company announcement published today, 20 October 2023, at 1 p.m. There was an…
Read More » -
Extremities
Inside information: Bioretec enters into the U.S. distribution agreement with Spartan Medical for the RemeOs™ screws
TAMPERE, Finland, Sept. 12, 2023 /PRNewswire/ — Bioretec Ltd, a pioneering company dedicated to advancing biodegradable orthopedic implants, has signed a distribution…
Read More » -
Financial
Bioretec has received Business Finland’s R&D grant for developing coatings for the next generation of biodegradable implants
TAMPERE, Finland, Sept. 6, 2023 /PRNewswire/ — Bioretec Ltd, a pioneering company dedicated to advancing biodegradable orthopedic implants, has received a grant…
Read More » -
Spine
Bioretec unveils its revitalized Scientific Advisory Board (SAB), focusing on driving innovations in orthopedic implants
TAMPERE, Finland, Aug. 16, 2023 /PRNewswire/ — Bioretec Ltd, a pioneering company dedicated to advancing orthopedic biodegradable implants, has refined and expanded…
Read More » -
Financial
Bioretec Ltd’s Half Year Report 2023 (unaudited): Historic achievement supported by the strong sales
TAMPERE, Finland, Aug. 11, 2023 /PRNewswire/ — This is a summary of Bioretec Ltd’s half year report 2023. The complete half year…
Read More » -
Extremities
Bioretec Ltd invests in a CNC machining center to increase the RemeOs™ production capacity
TAMPERE, Finland, June 13, 2023 /PRNewswire/ — Bioretec Ltd, a pioneer in bioresorbable orthopedic implants, has acquired a new CNC machining center…
Read More » -
Regulatory
Bioretec is the first in the world to receive FDA approval for a bioresorbable metal product
TAMPERE, Finland, March 30, 2023 /PRNewswire/ — Bioretec Ltd, a pioneer in bioresorbable[1] orthopedic implants, has today announced receiving the market authorization of…
Read More » -
Regulatory
Bioretec postpones Annual General Meeting to a later date
TAMPERE, Finland, March 17, 2023 /PRNewswire/ — Bioretec Ltd’s Board of Directors has today decided to reschedule the date of the company’s…
Read More » -
Financial
Bioretec Ltd’s financial statements bulletin 2022: We are delighted about the sales growth and look forward to future approvals
TAMPERE, Finland, Feb. 17, 2023 /PRNewswire/ — This is a summary of Bioretec Ltd’s financial statements bulletin for January-December 2022. The complete financial…
Read More » -
Regulatory
Bioretec updates its estimate of the timing for approval of the CE mark for the RemeOs™ trauma screw
TAMPERE, Finland, Nov. 4, 2022 /PRNewswire/ — Bioretec Ltd, a pioneer in biodegradable orthopedic implants, expects the European marketing authorization for the RemeOs™…
Read More » -
Extremities
Bioretec updates estimate of U.S. registration of RemeOs™ screws and expects approval in April 2023
TAMPERE, Finland, Oct. 14, 2022 /PRNewswire/ — Bioretec Ltd, a pioneer in bioresorbable orthopedic implants, continues to discuss the company’s RemeOs™ trauma…
Read More » -
Regulatory
Bioretec’s hybrid composite patent has been approved in Europe
TAMPERE, Finland, Sept. 8, 2022 /PRNewswire/ — The European Patent Office has announced to approve Bioretec Oy’s hybrid composite material patent application EP3782657A1…
Read More »